New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 23, 2014
11:00 EDTKERX, NSR, ITMN, WWE, WUBA, ARUN, SHLD, DTVOptions with decreasing implied volatility
Options with decreasing implied volatility: KERX NSR ITMN WWE WUBA ARUN SHLD DTV MACK WB
News For KERX;NSR;ITMN;WWE;WUBA;ARUN;SHLD;DTV From The Last 14 Days
Check below for free stories on KERX;NSR;ITMN;WWE;WUBA;ARUN;SHLD;DTV the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
07:28 EDTDTVDirecTV shares offer attractive opportunity, says Brean Capital
Subscribe for More Information
July 24, 2014
17:17 EDTKERXKeryx up 3% in after hours trading after Zerenex meets phase 3 primary end-point
Subscribe for More Information
July 23, 2014
16:18 EDTNSRNeuStar backs FY14 adjusted EPS view of $3.88-$4.05, consensus $3.74
Reaffirms FY14 revenue $945M-$970M, consensus $956.58M.
16:17 EDTNSRNeuStar reports Q2 adjusted EPS 95c, consensus 90c
Reports Q2 revenue $237.5M, consensus $233.05M.
July 21, 2014
11:19 EDTITMNInterMune July weekly volatility elevated
Subscribe for More Information
July 17, 2014
12:42 EDTITMNInterMune receives FDA Breakthrough Therapy Designation for pirfenidone
InterMune announced that pirfenidone has been granted Breakthrough Therapy Designation from the U.S. FDA. This designation is reserved for drugs that are intended to treat a serious or life threatening disease or condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints. Pirfenidone is an investigational treatment for adult patients with idiopathic pulmonary fibrosis.
July 16, 2014
17:22 EDTARUNAruba Networks initiated with a Neutral at Buckingham
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use